Anti-Acetylated lysine (25 µl, clone 7F8)

Referencia AS10707-25

embalaje : 25ul

Marca : Agrisera

Contact local distributor :


Teléfono : +1 850 650 7790

IKP

Anti-Acetylated lysine (25 µl, clone 7F8)

Product no: AS10 707-25

AS10 707-25  | Clonality: monoclonal  |  Host: Mouse  |  Reactivity: acetylated lysine

    Product Info
    Sub class: IgG1
    Immunogen:

    acetylated KLH

    Host: Mouse
    Clonality: Monoclonal
    Purity: Total IgG fraction. Protein G purified.
    Format: Liquid
    Quantity: 25 µl
    Storage: Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube.
    Tested applications: ELISA (ELISA), Immunocytochmistry/Immunofluorescence (ICC/IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western blot (WB)
    Recommended dilution: 1 : 100 (IHC), 1 : 1000 (WB)
    Reactivity
    Confirmed reactivity: Bovine, avian
    Predicted reactivity: Higher plants
    Not reactive in: No confirmed exceptions from predicted reactivity are currently known
    Additional Information
    Additional information: Protein G purified IgG2B in PBS, pH 7,4 with 0,09 % sodium azide and 50 % glycerol at concentration 1 mg/mlantibody detects Proteins containing acetylated lysine residues in ELISA and WBs, Does not detect non-acetylated lysine residues
    Additional information (application):

    1 µg of this antibody is sufficient to detect acetylated chicken erythrocyte histones (sodium butyrate-treated) using 20 µg total protein and ECL detection system

    Background
    Background:

    Post-translational modifications of proteins play critical roles in the regulation and function of many known biological processes. Proteins can be post-translationally modified in many different ways, and a common posttranscriptional modification of Lysine involves acetylation (1). The conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs) (2). Protein posttranslational reversible lysine Nε-acetylation and deacetylation have been recognized as an emerging intracellular signaling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (3).  

    Product Citations
    Selected references: Vigushin & Coombes (2004). Targeted histone deacetylase inhibition for cancer therapy. Curr. Cancer Drug Targets 4: 205-218.
    Reviews:
  • This product doesn't have any reviews.